Transcriptional regulation of CXCL5 in HIV-1-infected macrophages and its functional consequences on CNS pathology

Journal of Interferon and Cytokine Research

Volumn 35, Issue 5, 2015, Pages 373-384

  Guha, Debjani ^a   Klamar, Cynthia R ^a   Reinhart, Todd ^a   Ayyavoo, Velpandi ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; AUTACOID; CHEMOKINE;

APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HIV ASSOCIATED NEPHROPATHY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFLAMMATORY INFILTRATE; MACROPHAGE; MONOCYTE DERIVED MACROPHAGE; NERVE CELL NECROSIS; NEUROPATHOLOGY; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SUPERNATANT; TRANSCRIPTION REGULATION; UPREGULATION; CELL LINE; CENTRAL NERVOUS SYSTEM INFECTION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; NERVE CELL; PHYSIOLOGY; VIROLOGY; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

CELL LINE; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; CHEMOKINE CXCL5; CHEMOKINES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HIV INFECTIONS; HIV-1; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; NEURONS; NEUTROPHIL INFILTRATION; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 84928945117     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2014.0135     Document Type: Article

References (65)

1. Albright AV, Gonzalez-Scarano F. 2004. Microarray analysis of activated mixed glial (microglia) and monocyte-derived macrophage gene expression. J Neuroimmunol 157(1-2): 27-38.
2. Aravalli RN, Hu S, Rowen TN, Palmquist JM, Lokensgard JR. 2005. Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus. J Immunol 175(7):4189-4193.
3. Baston-Bust DM, Schanz A, Boddeker SJ, Altergot-Ahmad O, Krussel JS, Rein D, Hess AP. 2013. CXCL1 expression in human decidua in vitro is mediated via the MAPK signalling cascade. Cytokine 64(1):79-85.
4. Becker KM, Heinrichs-Graham E, Fox HS, Robertson KR, Sandkovsky U, O'Neill J, Swindells S, Wilson TW. 2013. Decreased MEG beta oscillations in HIV-infected older adults during the resting state. J Neurovirol 19(6):586-594.
5. Bersinger NA, Gunthert AR, McKinnon B, Johann S, Mueller MD. 2011. Dose-response effect of interleukin (IL)-1beta, tumour necrosis factor (TNF)-alpha, and interferon-gamma on the in vitro production of epithelial neutrophil activating peptide-78 (ENA-78), IL-8, and IL-6 by human endometrial stromal cells. Arch Gynecol Obstet 283(6):1291-1296.
6. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, So-droski J, Springer TA. 1996. The lymphocyte chemoat-tractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382(6594):829-833.
7. Brabers NA, Nottet HS. 2006. Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia. Eur J Clin Invest 36(7):447-458.
8. Buch S, Sui Y, Potula R, Pinson D, Adany I, Li Z, Huang M, Li S, Dhillon N, Major E, Narayan O. 2004. Role of interleukin-4 and monocyte chemoattractant protein-1 in the neuropatho-genesis of X4 simian human immunodeficiency virus infection in macaques. J Neurovirol 10 Suppl 1:118-124.
9. Campillo-Gimenez L, Casulli S, Dudoit Y, Seang S, Carcelain G, Lambert-Niclot S, Appay V, Autran B, Tubiana R, Elbim C. 2014. Neutrophils in antiretroviral therapy-controlled HIV demonstrate hyperactivation associated with a specific IL-17/IL-22 environment. J Allergy Clin Immunol [Epub ahead of print]; DOI: 10.1016/j.jaci.2014.05.040.
10. Carrero R, Cerrada I, Lledo E, Dopazo J, Garcia-Garcia F, Rubio MP, Trigueros C, Dorronsoro A, Ruiz-Sauri A, Mon-tero JA, Sepulveda P. 2012. IL1beta induces mesenchymal stem cells migration and leucocyte chemotaxis through NF-kappaB. Stem Cell Rev 8(3):905-916.
11. Cheung R, Ravyn V, Wang L, Ptasznik A, Collman RG. 2008. Signaling mechanism of HIV-1 gp120 and virion-induced IL-1beta release in primary human macrophages. J Immunol 180(10):6675-6684.
12. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. 1995. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8 + T cells. Science 270(5243):1811-1815.
13. Crawford TQ, Hecht FM, Pilcher CD, Ndhlovu LC, Barbour JD. 2013. Activation associated ERK1/2 signaling impairments in CD8 +T cells co-localize with blunted polyclonal and HIV-1 specific effector functions in early untreated HIV-1 infection. PLoS One 8(10):e77412.
14. D'Aversa TG, Yu KO, Berman JW. 2004. Expression of che-mokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat. J Neuro-virol 10(2):86-97.
15. Darbinyan A, Kaminski R, White MK, Darbinian-Sarkissian N, Khalili K. 2013. Polyomavirus JC infection inhibits differentiation of oligodendrocyte progenitor cells. J Neurosci Res 91(1):116-127.
16. Del Corno M, Liu QH, Schols D, de Clercq E, Gessani S, Freedman BD, Collman RG. 2001. HIV-1 gp120 and che-mokine activation of Pyk2 and mitogen-activated protein kinases in primary macrophages mediated by calcium-dependent, pertussis toxin-insensitive chemokine receptor signaling. Blood 98(10):2909-2916.
17. Devergne O, Peuchmaur M, Humbert M, Navratil E, Leger-Ravet MB, Crevon MC, Petit MA, Galanaud P, Emilie D. 1991. In vivo expression of IL-1 beta and IL-6 genes during viral infections in human. Eur Cytokine Netw 2(3): 183-194.
18. Duskova K, Nagilla P, Le HS, Iyer P, Thalamuthu A, Martinson J, Bar-Joseph Z, Buchanan W, Rinaldo C, Ayyavoo V. 2013. MicroRNA regulation and its effects on cellular transcriptome in human immunodeficiency virus-1 (HIV-1) infected individuals with distinct viral load and CD4 cell counts. BMC Infect Dis 13:250.
19. El-Hage N, Bruce-Keller AJ, Knapp PE, Hauser KF. 2008. CCL5/RANTES gene deletion attenuates opioid-induced increases in glial CCL2/MCP-1 immunoreactivity and activation in HIV-1 Tat-exposed mice. J Neuroimmune Pharmacol 3(4):275-285.
20. El-Hage N, Wu G, Wang J, Ambati J, Knapp PE, Reed JL, Bruce-Keller AJ, Hauser KF. 2006. HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of mi-croglia through the expression of MCP-1 and alternative chemokines. Glia 53(2):132-146.
21. Fontaine J, Poudrier J, Roger M. 2011. Short communication: persistence of high blood levels of the chemokines CCL2, CCL19, and CCL20 during the course of HIV infection. AIDS Res Hum Retroviruses 27(6):655-657.
22. Freitas M, Porto G, Lima JL, Fernandes E. 2008. Isolation and activation of human neutrophils in vitro. The importance of the anticoagulant used during blood collection. Clin Biochem 41(7-8):570-575.
23. Furler RL, Uittenbogaart CH. 2010. Signaling through the P38 and ERK pathways: a common link between HIV replication and the immune response. Immunol Res 48(1-3):99-109.
24. Gandhi N, Saiyed Z, Thangavel S, Rodriguez J, Rao KV, Nair MP. 2009. Differential effects of HIV type 1 clade B and clade C Tat protein on expression of proinflammatory and antiinflammatory cytokines by primary monocytes. AIDS Res Hum Retroviruses 25(7):691-699.
25. Gelman BB, Lisinicchia JG, Morgello S, Masliah E, Commins D, Achim CL, Fox HS, Kolson DL, Grant I, Singer E, Yiannoutsos CT, Sherman S, Gensler G, Moore DJ, Chen T, Soukup VM. 2013. Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort. J Acquir Immune Defic Syndr 62(5): 487-495.
26. Guha D, Nagilla P, Redinger C, Srinivasan A, Schatten GP, Ayyavoo V. 2012. Neuronal apoptosis by HIV-1 Vpr: contribution of proinflammatory molecular networks from infected target cells. J Neuroinflammation 9:138.
27. Harada A, Sekido N, Akahoshi T, Wada T, Mukaida N, Mat-sushima K. 1994. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol 56(5):559-564.
28. Ho DD, Sarngadharan MG, Resnick L, Dimarzoveronese F, Rota TR, Hirsch MS. 1985. Primary human T-lymphotropic virus type III infection. Ann Intern Med 103(6 (Pt 1)):880-883.
29. Hosking MP, Liu L, Ransohoff RM, Lane TE. 2009. A protective role for ELR+ chemokines during acute viral en-cephalomyelitis. PLoS Pathog 5(11):e1000648.
30. Ichikawa A, Kuba K, Morita M, Chida S, Tezuka H, Hara H, Sasaki T, Ohteki T, Ranieri VM, dos Santos CC, Kawaoka Y, Akira S, Luster AD, Lu B, Penninger JM, Uhlig S, Slutsky AS, Imai Y. 2013. CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin. Am J Respir Crit Care Med 187(1):65-77.
31. Katsikis PD, Mueller YM, Villinger F. 2011. The cytokine network of acute HIV infection: a promising target for vaccines and therapy to reduce viral set-point? PLoS Pathog 7(8):e1002055.
32. Kim JY, Ahn MH, Song HO, Choi JH, Ryu JS, Min DY, Cho MH. 2006. Involvement of MAPK activation in chemokine or COX-2 productions by Toxoplasma gondii. Korean J Para-sitol 44(3):197-207.
33. Klein RS, Williams KC, Alvarez-Hernandez X, Westmoreland S, Force T, Lackner AA, Luster AD. 1999. Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neuropathogen-esis of AIDS. J Immunol 163(3):1636-1646.
34. Kojima R, Taniguchi H, Tsuzuki A, Nakamura K, Sakakura Y, Ito M. 2010. Hypertonicity-induced expression of monocyte chemoattractant protein-1 through a novel cis-acting element and MAPK signaling pathways. J Immunol 184(9):5253-5262.
35. Kyriakis JM, Avruch J. 2001. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81(2):807-869.
36. Letendre SL, Zheng JC, Kaul M, Yiannoutsos CT, Ellis RJ, Taylor MJ, Marquie-Beck J, Navia B. 2011. Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals. J Neurovirol 17(1):63-69.
37. Lipton SA, Gendelman HE. 1995. Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 332(14):934-940.
38. Liu X, Shah A, Gangwani MR, Silverstein PS, Fu M, Kumar A. 2014. HIV-1 Nef induces CCL5 production in astro-cytes through p38-MAPK and PI3K/Akt pathway and utilizes NF-kB, CEBP and AP-1 transcription factors. Sci Rep 4:4450.
39. Mamik MK, Banerjee S, Walseth TF, Hirte R, Tang L, Borgmann K, Ghorpade A. 2011. HIV-1 and IL-1beta regulate astrocytic CD38 through mitogen-activated protein kinases and nuclear factor-kappaB signaling mechanisms. J Neuroinflammation 8:145.
40. Marro BS, Hosking MP, Lane TE. 2012. CXCR2 signaling and host defense following coronavirus-induced encephalomy-elitis. Future Virol 7(4):349-359.
41. Mei J, Liu Y, Dai N, Favara M, Greene T, Jeyaseelan S, Poncz M, Lee JS, Worthen GS. 2010. CXCL5 regulates chemokine scavenging and pulmonary host defense to bacterial infection. Immunity 33(1):106-117.
42. Merrill JE, Koyanagi Y, Chen IS. 1989. Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J Virol 63(10):4404-4408.
43. Nakayama K, Nakamura H, Koga M, Koibuchi T, Fujii T, Miura T, Iwamoto A, Kawana-Tachikawa A. 2012. Im-balanced production of cytokines by T cells associates with the activation/exhaustion status of memory T cells in chronic HIV type 1 infection. AIDS Res Hum Retroviruses 28(7): 702-714.
44. Nouailles G, Dorhoi A, Koch M, Zerrahn J, Weiner J, 3rd, Fae KC, Arrey F, Kuhlmann S, Bandermann S, Loewe D, Mollenkopf HJ, Vogelzang A, Meyer-Schwesinger C, Mittrucker HW, McEwen G, Kaufmann SH. 2014. CXCL5-secreting pulmonary epithelial cells drive destructive neutrophilic inflammation in tuberculosis. J Clin Invest 124(3):1268-1282.
45. Okabe H, Beppu T, Ueda M, Hayashi H, Ishiko T, Masuda T, Otao R, Horlad H, Mima K, Miyake K, Iwatsuki M, Baba Y, Takamori H, Jono H, Shinriki S, Ando Y, Baba H. 2012. Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts. Int J Cancer 131(10):2234-2241.
46. Palmer DL, Hjelle BL, Wiley CA, Allen S, Wachsman W, Mills RG, Davis LE, Merlin TL. 1994. HIV-1 infection despite immediate combination antiviral therapy after infusion of contaminated white cells. Am J Med 97(3):289-295.
47. Pitha PM. 2011. Innate antiviral response: role in HIV-1 infection. Viruses 3(7):1179-1203.
48. Qin S, Sui Y, Soloff AC, Junecko BA, Kirschner DE, Murphey-Corb MA, Watkins SC, Tarwater PM, Pease JE, Barratt-Boyes SM, Reinhart TA. 2008. Chemokine and cytokine mediated loss of regulatory T cells in lymph nodes during pathogenic simian immunodeficiency virus infection. J Immunol 180(8):5530-5536.
49. Schafer EA, Venkatachari NJ, Ayyavoo V. 2006. Antiviral effects of mifepristone on human immunodeficiency virus type-1 (HIV-1): targeting Vpr and its cellular partner, the glucocorticoid receptor (GR). Antiviral Res 72(3):224-232.
50. Skinner S, Adewale AJ, DeBlock L, Gill MJ, Power C. 2009. Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy. HIV Med 10(4):246-252.
51. Sun H, Chung WC, Ryu SH, Ju Z, Tran HT, Kim E, Kurie JM, Koo JS. 2008. Cyclic AMP-responsive element binding protein-and nuclear factor-kappaB-regulated CXC chemo-kine gene expression in lung carcinogenesis. Cancer Prev Res 1(5):316-328.
52. Tyor WR, Glass JD, Griffin JW, Becker PS, McArthur JC, Bezman L, Griffin DE. 1992. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 31(4):349-360.
53. Unemori EN, Amento EP, Bauer EA, Horuk R. 1993. Melanoma growth-stimulatory activity/GRO decreases collagen expression by human fibroblasts. Regulation by C-X-C but not C-C cytokines. J Biol Chem 268(2):1338-1342.
54. van Marle G, Henry S, Todoruk T, Sullivan A, Silva C, Rourke SB, Holden J, McArthur JC, Gill MJ, Power C. 2004. Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10. Virology 329(2):302-318.
55. Wang P, Bai F, Zenewicz LA, Dai J, Gate D, Cheng G, Yang L, Qian F, Yuan X, Montgomery RR, Flavell RA, Town T, Fikrig E. 2012. IL-22 signaling contributes to West Nile encephalitis pathogenesis. PLoS One 7(8):e44153.
56. Wilflingseder D, Mullauer B, Schramek H, Banki Z, Pruenster M, Dierich MP, Stoiber H. 2004. HIV-1-induced migration of monocyte-derived dendritic cells is associated with differential activation of MAPK pathways. J Immunol 173(12): 7497-7505.
57. Williams DW, Calderon TM, Lopez L, Carvallo-Torres L, Gaskill PJ, Eugenin EA, Morgello S, Berman JW. 2013. Mechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14+CD16+monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesis. PLoS One 8(7):e69270.
58. Williams R, Dhillon NK, Hegde ST, Yao H, Peng F, Callen S, Chebloune Y, Davis RL, Buch SJ. 2009. Proinflammatory cytokines and HIV-1 synergistically enhance CXCL10 expression in human astrocytes. Glia 57(7):734-743.
59. Xing HQ, Hayakawa H, Izumo K, Kubota R, Gelpi E, Budka H, Izumo S. 2009. In vivo expression of proinflammatory cytokines in HIV encephalitis: an analysis of 11 autopsy cases. Neuropathology 29(4):433-442.
60. Yang Y, Wu J, Lu Y. 2010. Mechanism of HIV-1-TAT induction of interleukin-1beta from human monocytes: involvement of the phospholipase C/protein kinase C signaling cascade. J Med Virol 82(5):735-746.
61. Ye L, Huang Y, Zhao L, Li Y, Sun L, Zhou Y, Qian G, Zheng JC. 2013. IL-1beta and TNF-alpha induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase. J Neurochem 125(6):897-908.
62. Zaremba J, Skrobanski P, Losy J. 2006. The level of chemokine CXCL5 in the cerebrospinal fluid is increased during the first 24 hours of ischaemic stroke and correlates with the size of early brain damage. Folia Morphol 65(1):1-5.
63. Zhou SL, Dai Z, Zhou ZJ, Wang XY, Yang GH, Wang Z, Huang XW, Fan J, Zhou J. 2012. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Hepatology 56(6):2242-2254.
64. Zink WE, Zheng J, Persidsky Y, Poluektova L, Gendelman HE. 1999. The neuropathogenesis of HIV-1 infection. FEMS Immunol Med Microbiol 26(3-4):233-241.
65. Zlotnik A, Yoshie O. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12(2):121-127.